Rivaroxaban in secondary prevention of cardioembolic stroke: standards and abnormal situations
Possibilities of antithrombotic therapy in prevention of cardioembolic stroke (CES) in patients with nonvalvular atrial fibrillation (AF) were significantly broadened after new oral anticoagulants (NOC) have been designed and launched into clinical practice (rivaroxaban being one of these agents). I...
Saved in:
| Main Authors: | A.V. Fonyakin, L.A. Geraskina |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2014-05-01
|
| Series: | Неврология, нейропсихиатрия, психосоматика |
| Subjects: | |
| Online Access: | https://nnp.ima-press.net/nnp/article/view/373 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
GENETIC PREDICTORS FOR CARDIOEMBOLIC STROKE IN PATIENTS WITH ATRIAL FIBRILLATION
by: V. A. Shulman, et al.
Published: (2014-10-01) -
Patient with cardioembolic stroke: clinical characteristics and typical features
by: O. I. Efimova, et al.
Published: (2020-06-01) -
Cardioembolic stroke: classification of causes and prevention strategies
by: A. V. Fonyakin, et al.
Published: (2021-12-01) -
THE PHARMACOKINETICS OF APIXABAN IN PATIENTS WITH CARDIOEMBOLIC STROKE IN ACUTE PHASE
by: A. V. Kryukov, et al.
Published: (2016-06-01) -
CURRENT VIEWS ON ANTITHROMBOTIC THERAPY IN NON-CARDIOEMBOLIC STROKE
by: A. V. Fonyakin, et al.
Published: (2017-05-01)